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Conquering obesity has become a major socio-
economic challenge. Here, we show that reduced
expression of the miR-25-93-106b cluster, or miR-
93 alone, increases fat mass and, subsequently,
insulin resistance. Mechanistically, we discovered
an intricate interplay between enhanced adipocyte
precursor turnover and increased adipogenesis.
First, miR-93 controls Tbx3, thereby limiting self-
renewal in early adipocyte precursors. Second,
miR-93 inhibits the metabolic target Sirt7, which we
identified as a major driver of in vivo adipogenesis
via induction of differentiation and maturation of
early adipocyte precursors. Using mouse parabiosis,
obesity in mir-25-93-106b–/– mice could be rescued
by restoring levels of circulating miRNA and subse-
quent inhibition of Tbx3 and Sirt7. Downregulation
of miR-93 also occurred in obese ob/ob mice, and
this phenocopy of mir-25-93-106b–/– was partially
reversible with injection of miR-93 mimics. Our data
establish miR-93 as a negative regulator of adipo-
genesis and a potential therapeutic option for obesity
and the metabolic syndrome.INTRODUCTION
Excess visceral adiposity is associated with a variety of meta-
bolic dysfunctions, such as insulin resistance, dyslipidemia,
hypertension, and inflammation. In contrast to subcutaneous
adipose tissue, enhanced visceral fat mass (evidenced as
increased waist circumference) is strongly correlated with higher1594 Cell Reports 12, 1594–1605, September 8, 2015 ª2015 The Aucardiometabolic risk (Klein et al., 2007). Intra-abdominal visceral
fat is biologically distinct from peripheral subcutaneous fat in
part by its production ofmore pro-inflammatory cytokines, which
promote insulin resistance, and less adiponectin (Hamdy et al.,
2006), which is protective against the development of type 2
diabetes and cardiovascular disease (Nanayakkara et al.,
2012). Several microRNAs (miRNAs) previously have been re-
ported to be involved in metabolism and adipogenesis. For
example, expression of the miR-17-92 cluster has been linked
to enhanced adipocyte differentiation by negatively regulating
tumor suppressor Rb2/p130 (Wang et al., 2008), and both miR-
93 and miR-106b have been reported to inhibit brown adipocyte
differentiation (Wu et al., 2013). Importantly, miR-93 expression
is decreased during hyperglycemia via repression ofmiR-93 pro-
moter activity (Long et al., 2010). Recently, it also was demon-
strated that miR-93 is overexpressed in subcutaneous adipose
tissue of young, pre-menopausal, overweight females with insu-
lin resistance: this was mechanistically linked to downregulation
of Glut4 (Chen et al., 2013). However, the role of the miR-25-93-
106b cluster, or miR-93 in particular, in the interconnected phe-
notypes of the metabolic syndrome had not yet been elucidated.
To clarify the role of the miR-25-93-106b cluster in adiposity, we
set out to identify its targets usingmiR-25-93-106b–/– mice as an
in vivo model.RESULTS
Enhanced Adiposity and Metabolic Syndrome in
mir-25-93-106b–/– Mice
The mir-25-93-106b–/– mice exhibit an increase in the size of
visceral fat pads (epigonadal fat; EWAT) on a standard chow
diet (Figure 1A). This phenotype was much more pronounced
in females, suggesting hormone dependency (Figure S1A).
High-fat diet (HFD) further enhanced the phenotype in boththors
(legend on next page)
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male and female mice (Figures S1B and S1C). Females also had
increased brown adipose tissue (BAT) (Figure S1D). Visceral fat
pad mass of female mir-25-93-106b–/– mice started increasing
at 8–9 weeks of age (data not shown), which translated into an
18.5% increase in total body weight (BW) by 40 weeks (Fig-
ure S1E). This was attributable to both a reduction in lean
mass (Figure S1F) and accretion of whole-body, relative fat
mass in females (Figure S1G). Differences in males were less
prominent (Figure S1H). In addition to enhanced visceral fat,
we found increased accumulation of subcutaneous white adi-
pose tissue (SWAT) in females, particularly in the perineal region
(Figures 1B and 1C). This excess adiposity resulted in severe
glucose intolerance and delayed response to glucose in mir-
25-93-106b–/– females (Figure 1D, left). In addition, the drop in
glucose levels in response to insulin administration was blunted
relative to controls, indicating insulin resistance (Figure 1D,
right). Consistent with this, endogenous insulin levels after fast-
ing or 2 hr after re-feeding were drastically increased (Figure 1E).
Taken together, mir-25-93-106b–/– mice are characterized by
enhanced adiposity leading to insulin resistance, a key feature
of the metabolic syndrome.
Enhanced Adiposity and Adipogenesis in
mir-25-93-106b–/– Mice
Energy expenditure (EE) was reduced inmir-25-93-106b–/– mice
during night hours when mice are most active (Figures 1F and
1G). Mir-25-93-106–/– mice had normal respiratory quotients
(Figure 1H). However, their reduced rearing activity (Figure 1I)
suggests an effect at the level of the CNS. Their food intake
was only slightly reduced (Figure 1J), consistent with increased
circulating levels of the adipose tissue-derived, anorectic hor-
mone leptin (Figure 1K). This most likely reflects leptin resis-
tance, as is observed in obese individuals when the homeostatic
negative feedback loop that normally regulates adipose mass is
disrupted (Leyva et al., 1998). The increased size of mir-25-93-
106b–/– fat pads was attributable to both an increase in the num-
ber of large adipocytes (hypertrophic cells) (Figure 1L) and the
total number of adipocytes (hyperplasia, Figure S1I). Consistent
with this, sorted early adipocyte precursors from mir-25-93-
106b–/– mice showed enhanced in vitro adipogenesis (Fig-
ure S1J). Lipid droplet accumulation was apparent in livers ofFigure 1. Enhanced Adiposity and Adipogenesis in miR-25-93-106b–/–
(A) Visceral fat (EWAT) in WT versus miR-25-93-106b–/– (KO) mice (top). Fat pad
(B) Computed tomography in female WT and KO mice illustrates total body fat (n
(C) Separate analysis for SWAT and EWAT content is shown (n = 13; *p < 0.05; q
(D) GTT in femaleWT and KOmice after injection of 2 g/kg BWglucose (n = 7; *p < 0
(n = 7; *p < 0.05) (right) are shown.
(E) Insulin levels in blood plasma after 12 hr of fasting and 2 hr after re-feeding a
(F) Indirect calorimetric measurements in WT versus KO mice. Energy expenditu
(G) Mean EE in WT versus KO mice is shown (n = 8; *p < 0.05).
(H) Respiratory quotient in WT versus KO mice is shown (n = 8; n.s., not significa
(I) Rearing activity in WT versus KO mice is shown (n = 8; *p < 0.05).
(J) Food intake in WT versus KO mice is shown (n = 8; *p = 0.09).
(K) Leptin in the blood plasma of KO and WT mice is shown (n = 16; *p < 0.05).
(L) Frequency distribution of the adipocyte area (size) in KO versus WT mice is s
(M) Numbers of LinCD24+CD29+SCA-1+CD34+ early adipocyte precursors (AP
*p < 0.05]).
All data are presented as mean ± SEM. See also Figures S1 and S2.
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or kidney (Figures S1K–S1N).
Molecular Characterization of Adipose Tissue in
miR-25-93-106b–/– Mice
Infiltration of pro-inflammatory CD11c+CD11b+ macrophages
into white visceral fat has been linked to insulin resistance (Went-
worth et al., 2010), and mir-25-93-106b–/– mice had increased
infiltration relative to controls (Figure S2A). Concordant with
enhanced recruitment of inflammatory cells, stromal cell-derived
factor-1 (SDF-1) was augmented, and pro-inflammatory factors
interleukin-6 (IL-6) and tumor necrosis factor alpha (TNF-a)
were increased (Figure S2B). We also noted enhanced recruit-
ment of bone marrow-derived CD45+ fibroblast activation pro-
tein (FAP)+ stromal cells into visceral fat (Phillips et al., 2004; Fig-
ure S2C). Intriguingly, size and number of mesenchymal colonies
also were increased in mir-25-93-106b–/– mice (Figure S2D).
To elucidate whether differences are already apparent in
adipocyte progenitors, we analyzed mesenchymal progenitor
cells defined as CD105+SCA-1+ cells, and we detected higher
numbers of these progenitors in the visceral fat pad of mir-
25-93-106b–/– mice relative to controls (Figure S2E). Moreover,
there were more early adipocyte progenitors (defined as
LinCD24+CD29+SCA-1+CD34+ cells [Berry et al., 2014; Rode-
heffer et al., 2008]) in adult visceral adipose tissue of mir-
25-93-106b–/– mice. This likely contributes to their enhanced
adiposity (Figures 1M and S2F). Numbers of early adipocyte
progenitors in both visceral and subcutaneous fat of mir-25-
93-106b–/– mice started to rise at 4 weeks of age and reached
a maximum at 8 weeks (Figure S2G).
MiR-93 Inhibits Adipogenesis
To elucidate the roles of individual members of the miR-25-93-
106b cluster in adipogenesis, we determined their expression
in non-obese wild-type (WT) mice versus obese, leptin-deficient
(ob/ob) mice. MiR-93 and miR-106b were robustly expressed in
many tissues of WT mice, including visceral and subcutaneous
fat (Figure S3A). MiR-93 was also significantly downregulated
in visceral fat of ob/ob mice (Figure 2A; Table S1), suggesting
a crucial role for miR-93 in visceral adipogenesis (Figure 2A).
Indeed, inhibition of miR-93 strongly promoted in vitro adipocyteMice
s of white (EWAT) and brown (BAT) fat (bottom) are shown.
= 14; *p < 0.05; quantification [left] and representative images [right]).
uantification [top] and representative images [bottom]).
.05) (left) and ITT in femaleWT and KOmice after injection of 1 IU/kg BW insulin
re shown (n = 8; *p < 0.05, **p < 0.05 versus WT).
re (EE) was recorded for a period of two consecutive nights (gray shade).
nt).
hown (n R 317 adipocytes; inset, representative images).
s) are shown (representative pictures, left; quantification, right [n = 4 mice;
thors
Figure 2. MiR-93 Inhibits Adipogenesis
(A) Expression of miR-25, miR-93, and miR-106b in total visceral fat of male obese ob/ob versus C57Bl/6J mice (28 weeks) is shown.
(B) 3T3-L1 pre-adipocytes transduced with control or miR-93 lentiviral construct. Spontaneous differentiation was quantified by Oil Red O staining (left) or
LipidTOX staining (middle) with representative images (right).
(legend continued on next page)
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differentiation. In addition, miR-106b appeared to play a role in
adipocyte differentiation (Figure S3B).
Given that miR-93 and miR-106b share putative target RNAs
Tbx3 and Sirt7 (Figure S3C), we decided to focus on miR-93.
Indeed, overexpression of miR-93 repressed the normal spon-
taneous differentiation of 3T3-L1 pre-adipocytes into mature
adipocytes (Figure 2B). In contrast, miR-93 antagomiR
enhanced adipogenesis in WT early adipocyte precursors (Fig-
ures 2C–2E). We then tested whether miR-93 antagomiRs
were capable of enhancing adipogenesis in vivo using freshly
sorted early adipocyte precursor cells pretreated with miR-93
antagomiR. Occipital subcutaneous implantation of miR-93
antagomiR-treated early adipocyte progenitors produced larger
adipose deposits relative to control-treated cells (Figures 2F,
S3D, and S3E).
MiR-93 Counteracts Self-Renewal of Adipocyte
Precursor via Tbx3
In silico prediction with http://www.microRNA.org identified
numerous potential miR-93 targets. We focused on the tran-
scription factor T-box 3 (Tbx3) based on its demonstrated role
in maintaining pluripotency via regulation of Nanog, Sox2,
Oct4, and Klf4 (Han et al., 2010; Figure 3B). Indeed, Tbx3 and
the stemness genes Nanog and Oct4 were consistently overex-
pressed in early adipocyte precursor cells and pre-adipocytes in
WT mice, but levels in mir-25-93-106b–/– cells were further
increased (Figures 3A–3C). In addition, Tbx3 was expressed
early during in vitro adipocyte differentiation (Figure S4A). Using
30UTR constructs, we found that miR-93 mimics inhibit Tbx3-
30UTR-regulated luciferase activity, thereby confirming Tbx3 as
a target for miR-93 (Figure 3D).
To elucidate the functional role for Tbx3 in early adipocyte pre-
cursors, we knocked down Tbx3 in adipose tissue in mice kept
on a 60% HFD to promote in vivo adipogenesis, which resulted
in reduced numbers of early adipocyte precursors (Figure 3E). To
corroborate these data, we ablated Tbx3 in mature adipocytes
using adiponectin-Cre (Adi-Cre;Tbx3fl/fl), and we employed
PDGFRa-Cre to eliminate Tbx3 in early adipocyte precursors,
pre-adipocytes, and mature adipocytes (PDGFRa-Cre;Tbx3fl/fl,
Figure 3F; Berry and Rodeheffer, 2013). Adult Adi-Cre;Tbx3fl/fl
mice showed no adipose tissue-related phenotypes with
the exception of a few females with slightly reduced gross adi-
pose tissue and diminished CD31CD45CD24+CD34+SCA-
1+CD29+ early adipocyte precursors (Figure S4B). Unfortunately,
PDGFRa-Cre;Tbx3fl/fl mice were not viable postnatally, most
likely due to a lethal cardiac phenotype (Frank et al., 2012). In
WT mice at fetal stages E17.5-18.5, when adipocyte precursors,
but not yet adipose tissue (Chau et al., 2014), are present, about
20% of CD31CD45CD24+CD34+CD29+ cells in fresh fetal tis-(C) WT pre-adipocytes treated with antagomiR against control or miR-93. C/EBP
(right) illustrate double staining for LipidTOX and C/EBPa.
(D) Quantification (left) and representative flow cytometry blots (right) for LipidTO
(E) Western blot analysis for protein expression of PPARg and adiponectin in WT p
used as a loading control.
(F) In vivo adipogenesis at the occipital skull region of nudemice (circled by hash-l
fat tissue; immunostaining for PPARg to detect cells of adipocyte lineage (fourth
All data are presented as mean ± SEM. See also Figure S3.
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(Figure 3G). For PDGFRa-Cre;Tbx3fl/fl mice surviving to the
same fetal stages, we observed a reduced number of PDGFRa+
early adipocyte precursors, consistent with a crucial role for
Tbx3 in these cells.
To test whether loss of Tbx3 prevents enhanced adipogenesis
in response to miR-93 antagomiRs, PDGFRa+ early adipocyte
precursors were derived from first-passagemouse embryonic fi-
broblasts (MEFs), pretreatedwithmiR-93 or control antagomiRs,
and induced to differentiate into adipocytes (Rosen and
MacDougald, 2006). While inhibition ofmiR-93 resulted in higher
numbers of lipid droplet+ adipocytes in WT cells, this effect was
absent in Tbx3–/– cells, which in contrast showed reduced lipid
filling of adipocyte precursors (Figures 3H–3J). These results
demonstrate that Tbx3 is a functional downstream target of
miR-93 and plays an important role in embryonic early adipocyte
precursors and their differentiation into adipocytes.
MiR-93 Controls Adipogenesis via Sirt7
Although the mammalian Sirtuin-7 (Sirt7) has a postulated role in
adipogenesis (Shin et al., 2013), its physiological function re-
mains largely unclear (Barber et al., 2012). Sirt7 is another pre-
dicted target of miR-93 (Figure S3C) and is induced early during
in vitro adipocyte differentiation (Figure S4A). As predicted, miR-
93 inhibited Sirt7 and adipogenesis (Figure 4A). Consistent with
this, expression of Sirt7 was enhanced in the stromal vascular
fraction of visceral fat in mir-25-93-106b–/– (Figure 4B, left) and
ob/ob mice (Figure 4B, middle), respectively, the latter corre-
lating with decreasedmiR-93 levels in thesemutants (Figure 2A).
Moreover, 24-hr treatment of 3T3-L1 pre-adipocytes with miR-
93 antagomiR caused upregulation of Sirt7 (Figure 4B, right).
Sirt7 was overexpressed in early adipocyte precursor cells and
pre-adipocytes in WT mice, but levels in mir-25-93-106b–/–
mice were overall higher (Figure 4C). This was validated at the
protein level using SIRT7 immunofluorescence (Figure 4D).
On the other hand, gain-of-function experiments with miR-93
mimics injected into the visceral fat pads of ob/obmice resulted
in decreased nuclear SIRT7 immunoreactivity (Figure 4E).
To conclusively validate that miR-93 inhibits Sirt7, the Sirt7-
30UTR-Gaussia luciferase (Gluc) reporter was transduced into
HEK293 cells, followed by transfection with miR-93 mimics.
This led to marked suppression of luciferase activity (Figure 4E).
Finally, the crucial role of Sirt7 in adipogenesis was demon-
strated directly by Sirt7 knockdown, which resulted in reduced
Oil Red O and adipocyte-lineage-marker staining for FABP4
(Figure 4F). Furthermore, expression of Pparg, C/ebpa, and Adi-
poq was decreased in EWAT of Sirt7–/– mice (Figures 4H–4J).
Early adipocyte precursorswere reduced inSirt7–/– mutants rela-
tive to controls (Figure 4K), as was expression of adipogenesisa+ cells (left) and LipidTOX+ cells (middle) and representative confocal images
X lipid staining are shown (n = 4; p < 0.05).
re-adipocytes treated with antagomiR against control ormiR-93. GAPDH was
ine, first row). DAPI (second row) and LipidTOX (third row) staining of explanted
row); and quantification of the volume (right) are shown (n = 6; *p < 0.05).
thors
Figure 3. miR-93 Counteracts Self-Renewal of Adipocyte Precursors via Tbx3
(A) MiR-93 inhibits expansion of early APs and pre-adipocytes via inhibition of Tbx-3.
(B) (Left) Relative expression of Tbx3 in early APs was measured by quantitative real-time PCR (n = 3; *p < 0.05). (Right) Relative expression of pluripotency-
associated genes in early APs was measured by quantitative real-time PCR (n = 3; *p < 0.05).
(legend continued on next page)
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markers in response to in vitro adipocyte differentiation (Figures
4L and 4M). Finally, the increase in lipid droplet+ cells observed in
response to miR-93 antagomiR treatment was diminished in
Sirt7–/– mice, demonstrating that Sirt7 is a functionally relevant
miR-93 target (Figure 4N).
Circulating Endogenous Factors or Local Injection of
miR-93 Reduces Size of Visceral Fat Pads
Circulating adiponectin levels were higher in WT females
compared to WT males (Luque-Ramı́rez et al., 2013) and
reduced in female mir-25-93-106b–/– mice (Figure 5A), confirm-
ing the endocrine function of visceral adipose tissue. Intriguingly,
adiponectin levels in mir-25-93-106b–/– mice could be rescued
by transplantation with WT bone marrow cells (Figure 5B). This
reveals that adiponectin is not a direct target of miR-93, but
rather an indirect factor modulated in response to the metabolic
abnormalities in thesemutants. This predicts that systemic deliv-
ery of the miR-25-93-106b cluster or miR-93 should reduce
visceral fat burden. Non-obese WT females had a higher circu-
lating miR-93 level compared to WT males, while mir-25-93-
106b–/– mice did not have detectable miR-93 levels and served
as a negative control (Figures 5C and S5A). Consistent with the
notion that miR-93 expression is estrogen dependent, miR-93
levels increased during pregnancy and decreased after
ovarectomy (Figure S5B). To validate that circulating miR-93 is
functionally active and capable of inhibiting Sirt7, HEK293 cells
expressing the Sirt7-30 UTR-Gaussia luciferase reporter were
exposed to either 20% WT or mir-25-93-106b–/– plasma; WT
plasma reduced reporter activity by 50%, but there was no
response to KO plasma (Figure 5D).
To investigate whether circulating miRNA can rescue mir-
25-93-106b–/– phenotypes and reduce visceral fat, we created
parabiotic pairs from female WT and mir-25-93-106b–/– mice
(Figure 5E). After 8 weeks, we observed reduced visceral and
subcutaneous fat in mir-25-93-106b–/– mice (Figures 5F and
5G), accompanied by reduced levels of Sirt7 and Tbx3 (Fig-
ure 5H) and normalization of adiponectin and leptin plasma
levels (Figures S5C–S5F). We tested the therapeutic effect of
restoring miR-93 levels by locally injecting liposomal miR-93
into the visceral fat of ob/ob mice (Figure S5G), which resulted
in reduced visceral fat after 4 weeks (Figure 5I). Strikingly,
glucose tolerance had already improved at this point, confirming(C) Expression of Tbx3 (left) in mature adipocytes (MADs), stromal-vascular pre
indicating MADs and by the dotted line (n = 4; *p < 0.05 versus MADs, right). Expr
mice is shown. Baseline levels of WT mice are indicated by the dotted line (n = 4
(D) 30UTR-Tbx3 Gaussia luciferase activity in HEK293 in the presence or absenc
(E) Injection of lentiviral shTbx3 into the adipose tissue of miR-25-93-106b–/– mice
pictures (left) and quantification (right) (n = 3; *p < 0.05).
(F) Scheme indicating MADs as targets of adiponectin and APs as targets of PDGF
to ablate Tbx3 in MADs and APs, respectively, is shown.
(G) Flow cytometry of early APs from fetuses (E17.5–18.5) of PDGFRa-Cre;Tbx3fl/
APs (left) is shown and quantified (right).
(H) Early APs from PDGFRa-Cre;Tbx3fl/fl mice versus controls were sorted for exp
confluency differentiated into adipocytes for 4 days in the presence or absence o
analyzed (n = 4; *p < 0.05 for WT + miR-93-ANT versus WT + ctrl-ANT, **p < 0.05
miR-93-ANT versus WT + miR-93-ANT).
(I and J) Representative flow cytometry (I) and images of the lipid-droplet-contai
All data are presented as mean ± SEM. See also Figure S4.
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aimed at reversing the obese phenotype in female mir-25-93-
106b–/– mice (Figure 5K). We reconstituted miR-93 into mir-25-
93-106b–/– bone marrow-derived stromal cells (Figure 5L), and
we injected reconstituted or control cells into the perineal adi-
pose tissue. After 12 weeks, flow cytometry revealed reduced
numbers of early adipocyte precursor cells (Figure 5M) and
PPARg+ cells (Figure 5N) in the perineal tissue of mice treated
with miR-93-reconstituted cells, indicating successful reversal
of adiposity.
DISCUSSION
Mir-25-93-106b–/– mice have increased intra-abdominal, peri-
neal, and subcutaneous fat and subsequent increased insulin
resistance. Consistent with this, obese ob/ob mice have signifi-
cant downregulation ofmiR-93 (Ventura et al., 2008) andmiR-93
also is downregulated in hyperglycemia (Long et al., 2010). Thus,
our data suggest a vicious cycle in which pre-diabetic conditions
characterized by impaired glucose tolerance and insulin resis-
tance lead to reduced miR-93 levels that in turn accelerate
adipogenesis, worsening the diabetic condition and leading to
further suppression of miR-93. Mechanistically, we show that
suppression of miR-93 augments white adipose tissue by
increasing adipocyte precursors through the pluripotency-asso-
ciated transcription factor Tbx3 and by increasing adipogenesis
through Sirt7. Restoring miR-93 by either systemic delivery in a
parabiosis model or direct injection into the visceral fat pads
reduced fat mass and improved insulin sensitivity. These data
demonstrate that miR-93 serves as an important regulator for
in vivo visceral white fat adipogenesis.
Increased fat mass in obesity is currently attributed to two
mechanisms: adipocyte hypertrophy, in which pre-existing adi-
pocytes increase their size due to lipid accumulation; and adipo-
cyte hyperplasia, leading to increased numbers of adipocytes
by differentiation of pre-adipocytes. New adipocytes in vivo
are derived from progenitors that recently have been described
as early adipocyte progenitor cells and are defined as Lin-
CD24+CD29+CD34+SCA-1+ cells resident in the adult white
adipose tissue vascular stroma (Berry and Rodeheffer, 2013; Ro-
deheffer et al., 2008). Here we show that these early adipocyte
progenitors are increased in the enhanced abdominal and-adipocytes (SVFs), and early APs. Baseline levels are given in the first bar
ession of Tbx3 in MADs, SVFs, and early APs inmiR-25-93-106b–/– versus WT
; *p < 0.05 for miR-25-93-106b–/– versus WT).
e of miR-93 mimics is shown (n = 3, *p < 0.05 for miR-93 mimic versus Ctrl).
, followed by flow cytometric analysis of early APs is shown by representative
Ra. The generation of Adiponectin-Cre;Tbx3fl/fl and PDGFRa-Cre;Tbx3fl/flmice
fl mice versus controls (n = 5; *p < 0.05). Representative flow cytometry of early
ression of early AP markers, including expression of PDGFRa, cultured, and at
f miR-93 or control antagomiRs. LipidTOX+ lipid-droplet-containing cells were
for Tbx3mutant + ctrl-ANT versus WT + ctrl-ANT, ***p < 0.05 for Tbx3mutant +
ning cells (J) are displayed.
thors
(legend on next page)
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subcutaneous fat of mir-25-93-106b–/– mice, suggesting that
increased fat mass is not merely related to adipocyte hyperpla-
sia, but to enhanced generation of new adipocytes. Intriguingly,
this difference was only observed in younger mice (8 weeks),
while older mice (18 weeks) showed a sharp drop in the number
of early adipocyte progenitors, so that no later differences
could be observed between WT and mir-25-93-106b–/– mice.
Moreover, we demonstrated that metabolic changes, such as
reduced EE due to low rearing activity, contribute to increased
fat mass. However, we cannot discriminate whether these meta-
bolic disturbances are the cause or consequence of some or all
of the mir-25-93-106b–/– phenotypes. Our data support the
postulate that early progenitor cells predominantly play a role
in obesity during adolescence and early adulthood, while adipo-
genesis is mostly driven by adipocyte hyperplasia later in life.
Adipose tissue is not a quiescent organ: rapid turnover of the
adipocyte population has been described (Rigamonti et al.,
2011). About 5% of pre-adipocytes are replicating at any time
and 1%–5% of adipocytes are replaced each day. This process
appears to be tightly controlled by miR-93. Our observation that
pretreatment with miR-93 antagomiR increases formation of
adipocyte tissue in vivo validates the inhibitory role of miR-93
on in vivo functionality of early adipocyte precursors. Together
with the excess expansion of the pool of early adipocyte progen-
itor in mir-25-93-106b–/– mice, our data suggest enhanced self-
renewal as the driving mechanism.
Several miRNAs are key regulators of stem cell maintenance
and promotion of differentiation (Gangaraju and Lin, 2009). For
example, miR-302 and miR-290 regulate self-renewal in embry-
onic stem cells (Le Bot, 2012). Notably, the role of miRNAs
for self-renewal in early adipocyte precursors had not been
described previously. In our search for putative stem cell-related
targets that might explain the expansion of the early adipocyteFigure 4. MiR-93 Controls Adipogenesis via Sirt7
(A) MiR-93 inhibits pro-adipogenic Sirt7.
(B) Sirt7 mRNA (and protein in inset) expression in WT versus mir-25-93-106b–/–
mice (n = 3; *p < 0.05, middle), and expression of Sirt7 in the presence of miR-93 a
time qPCR (n = 3; *p < 0.05, right) are shown.
(C) Expression of Sirt7 (left) in MADs, SVFs, and early APs. Baseline levels are give
MADs). (Right) Expression of Sirt7 in MADs, SVFs, and early APs inmiR-25-93-10
dotted line (n = 4; *p < 0.05 for miR-25-93-106b–/– versus WT).
(D) Quantification of Sirt7 immunofluorescence (green) in the presence of miR-93
(right) and representative images (left) are shown.
(E) Immunohistochemistry for SIRT7 in WT versus ob/ob mice following treatme
30UTR-Gaussia luciferase activity in HEK293 in the presence or absence of miR-
(F–I) Oil Red O staining (left), FABP4 immunostaining (middle), and quantification
adipocytes following Sirt7 knockdown (F) as demonstrated by western blot for S
EWAT of Sirt7 KO versus WT mice is shown. Pparg (I, middle) and C/ebpa (I, right
*p < 0.05).
(J) Adiponectin immunostaining in frozen sections from EWAT of Sirt7 KO versus
(right; n = 4–5; *p < 0.05).
(K) Flow cytometry of early APs in Sirt7 KO versus WT. Representative images (l
(L) In vitro fat differentiation ofSirt7KOandWT-derived sorted early APs. Confoca
of lipid droplets (right) identified by the lipid stain LipidTOX (DAPI is nuclear stain
(M) Protein expression of adiponectin (day 8 of fat differentiation) and leptin, C/EB
the loading control.
(N) In vitro fat differentiation of Sirt7 KO and WT-derived sorted early APs for 8 day
representative pictures (top) are displayed (n = 6; *p < 0.05).
All data are presented as mean ± SEM. See also Figure S4.
1602 Cell Reports 12, 1594–1605, September 8, 2015 ª2015 The Auprecursor pool following suppression of miR-93, we identified
the transcription factor Tbx3 as a candidate. Indeed, Tbx3 pro-
motes mesendodermal differentiation during embryogenesis
(Weidgang et al., 2013). Our data from fetuses in which Tbx3
was ablated in PDGFR cells support this notion and demonstrate
a key role for Tbx3 in early adipocyte precursors. In pluripotent
stem cells, Tbx3 maintains pluripotency, promotes self-renewal,
and facilitates reprogramming by direct binding of the Oct4 pro-
moter (Han et al., 2010). Consistent with this, a diabetic microen-
vironment enhances Oct4 and Nanog expression in human
visceral-derived adipose stem cells (Dentelli et al., 2013). Tbx3
overexpression also causes mammary gland hyperplasia and in-
creases mammary stem-like cells in an inducible transgenic
mouse model (Liu et al., 2011). Here we show that Tbx3 and
downstream transcriptional regulators of the pluripotency
network, such as Nanog and Oct4, also are increased in early
adipocyte progenitor cells of mir-25-93-106b–/– mice compared
to WT littermates. However, our study does not distinguish
whether it is these pluripotency-associated factors or other un-
known regulators that maintain cells in the precursor state or
promote adipocyte lineage commitment. As functional proof of
its role in the self-renewal capacity of early adipocyte precursors,
we found that knockdown and knockout (KO) of Tbx3 reduced
the number of adipocyte precursors in vivo. Also, we showed
that Tbx3 is a direct target of miR-93 in vitro.
In addition to enhanced early adipocyte progenitor activity,
increased fat mass in mir-25-93-106b–/– mice may be related
to increased adipogenesis with lipid accumulation in pre-existing
or newly formed adipocytes. Indeed, we provide evidence for
this second mechanism of action. Following expansion of early
adipocyte precursors via Tbx3 during early adolescence, subse-
quent Sirt7 activity (another predicted target of miR-93) drives
adipogenesis. This eventually materializes as increased fat(KO) mice (n = 5; *p < 0.05, western blot left), WT versus ob/ob leptin-deficient
nd control antagomiR in 3T3-L1 after 3 days of adipocyte differentiation by real-
n in the first bar indicating MADs and by the dotted line (n = 4; *p < 0.05 versus
6b–/– versus WTmice is shown. Baseline levels of WT mice are indicated by the
and control antagomiR in 3T3-L1 cells after 24 hr of adipocyte differentiation
nt with miR-93 mimics (left), quantification of SIRT+ cells (middle), and Sirt7-
93 mimics (right) are shown (n = 4; *p < 0.05).
of FABP4 staining (n = 7; *p < 0.05, right) in human adipose tissue-derived pre-
IRT7 (G). Lack of SIRT7 protein expression (H) and mRNA expression (I, left) in
) mRNA expression in EWAT tissue of Sirt7 KO versus WTmice is shown (n = 3;
WT mice is depicted in representative images (left) and quantitative analysis
eft) and quantification (right) are shown (n = 4; *p < 0.05).
l microscopy analysis shows nuclear C/EBPa immunostaining (left) and analysis
). Quantification and representative pictures are exhibited (n = 7; *p < 0.05).
Pa, and PPARg (day 4) in Sirt7 KO versus WT-derived early APs. GAPDH was
s in the presence of miR-93 or control antagomiR. Quantification (bottom) and
thors
(legend on next page)
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mass in adulthood. The Sirtuin family of nicotinamide adenine
dinucleotide (NAD+)-dependent deacetylases has a well-estab-
lished role in energy metabolism. However, the role of the
more recently described family member Sirt7 in metabolic regu-
lation has not yet been well defined. Mechanistically, Sirt7 spe-
cifically deacetylates histone H3 lysine 18 (H3K18) and promotes
transcriptional repression (Barber et al., 2012). Although it was
reported that Sirt7–/– mice have less visceral fat (Shin et al.,
2013), the regulation of adipogenesis by Sirt7 had not been fully
explored. We now provide conclusive evidence that Sirt7 is a
direct target of miR-93 and regulates the Sirt7-30UTR-Gaussia
luciferase reporter. Following Sirt7 knockdown in vitro and
Sirt7 KO in vivo, adipogenesis in vitro and adiposity in vivo
were both clearly reduced and demonstrate a role for Sirt7 in
promoting obesity.
The metabolic and health consequences of increased fat
mass, especially visceral fat, are serious: insulin resistance and
adipocyte dysfunction. Therefore, inhibition of adipogenesis via
upregulation of miR-93 plays a crucial role in attenuating meta-
bolic disorders and, subsequently, ameliorating the increased
cardiovascular risk. Intriguingly, we provide two lines of evidence
that enhancing miR-93 levels indeed reduces fat volume and
mass as well as secondary metabolic alterations. First, we used
a parabiosis model to systemically deliver WT miRNA to mir-
25-93-106b–/– mice via cross-circulation that is spontaneously
established between the two parabionts, and we demonstrated
that levels of miR-93 are indeed reconstituted in the parabiotic
mir-25-93-106b–/– partner. However, levels of non-miR-93 tar-
gets, such as adiponectin and leptin, also were normalized and
we cannot preclude their contribution to the reversal of the fat
phenotype in parabiotic partners. Second, we injected miR-93
directly into the intra-abdominal fat pads of ob/ob mice.
Both approaches resulted in a similarly improved phenotype,
demonstrating that miR-93 is crucial and a tractable therapeutic
intervention for inhibiting excessive adipogenesis. However,
when consideringmiR-93mimics as potential therapeutic agents
to conquer obesity, we must consider that miR-93 frequently is
overexpressed in human cancer and has been reported to pro-
mote tumor growth (Fang et al., 2011). Indeed, cancer-induced
cachexia might be further enhanced or even initiated by tumorsFigure 5. Circulating Endogenous Factors or Local Injection of miR-93
(A) Adiponectin plasma levels in WT versus mir-25-93-106b–/– (KO) mice are sho
(B) Adiponectin plasma levels in female KO mice following transplantation with W
(C) Levels of miR-93 in peripheral blood plasma of female and male WT and miR
(D) Sirt7-30UTR and mutated Sirt7-30UTR luciferase activity in HEK293 in the pres
*p < 0.05).
(E) Schematic illustrates the parabiosis experiments.
(F) Representative visceral fat pads from parabiotic pairs 8 weeks after surgical
(G) Quantification of (F) is shown (n = 6–8 visceral fat pads; *p < 0.05).
(H) mRNA expression of Tbx3 and Sirt7 in EWAT as well as miR93 levels in plasm
(I) Visceral fat pads of male obese ob/ob mice 4 weeks after local injection of miR
*p < 0.05).
(J) GTT in obese ob/ob mice following treatment with miR-93 mimics versus con
(K and L) In vivo reversal of the obese phenotype of female KO mice. Injection o
cutaneous perineal region (arrows) is shown. Gross morphology in situ (K, top)
histological analysis (bottom) is shown.
(M) Flow cytometry of early AP in reversed (bottom, miR-93) adipose tissue relat
(N) Quantification of PPARg+ adipocytes is shown (n = 3; *p < 0.05).
All data are presented as mean ± SEM. See also Figure S5.
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has been found to function as a tumor suppressor in some con-
texts (Liu et al., 2012). Therefore, additional studies are needed
to fully understand the role of miR-93 in cancer.
EXPERIMENTAL PROCEDURES
Animal Studies
Studies were performed with miR-25-93-106b–/– mice and their littermates on
C57BL/6J background (a kind gift of Andrea Ventura) and ob/obmice from The
Jackson Laboratory. Parabiotic couples of female WT and mir-25-93-106b–/–
mice were created as previously published (Aicher et al., 2007). All animal
studies were approved by the Institute’s Institutional Animal Care and Use
Committee (CBA 26_2009, CBA 25_2009, CBA 68_2013, and PPL70-8129).
Glucose Measurements
To perform the glucose tolerance test (GTT) and insulin tolerance test (ITT),
fasting glucose was measured in mice after a 12-hr fast. Blood samples to
obtain serum were drawn retroorbitally. For the GTT, mice were intraperitone-
ally injected with 2 g/kg BW glucose (Sigma-Aldrich). For the ITT, 1 IU/kg BW
insulin (Sigma-Aldrich) was intraperitoneally injected. To measure serum
glucose, blood samples were drawn at 30, 60, and 120 min post-injection.
Serum glucose (in mmol/l) was determined using an ABX Pentra 400 clinical
chemistry analyzer (Horiba ABX Diagnostics).
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
five figures, and one table and can be found with this article online at http://
dx.doi.org/10.1016/j.celrep.2015.08.006.
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